Sfoglia per Autore
Immunophenotypic profile and cytogenetic aberrations detected by interphase FISH in B-CLL patients
2011-01-01 Ruggeri M; Caltagirone S; Gilestro M; Aschero S; Astolfi M; Oddolo D; Saraci E; Muccio VE; Bergui L; Coscia M; Omedè P; Boccadoro M
12p, 1p, 1q, 5q, 11q ABNORMALITIES AND IMMUNOPHENOTYPE IN MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE, MULTIPLE MYELOMA AND PLASMA CELL LEUKEMIA.
2010-01-01 Ruggeri M; Caltagirone S; Gilestro M; Aschero S; Astolfi M; Oddolo D; Saraci E; Bruno B; Palumbo A; Bringhen S; Cavallo F; Omedè P; Boccadoro M
Consolidation with Bortezomib, Thalidomide and Dexamethasone Induces Molecular Remissions in Autografted Multiple Myeloma Patients
2007-01-01 Marco Ladetto; Gloria Pagliano; Ilaria Avonto; Loredana Santo; Simone Ferrero; Federica Cavallo; Monica Astolfi; Patrizia Pregno; Claudia Crippa; Anna Marina Liberati; Vincenzo Callea; Luca De Rosa; Antonietta Falcone; Mariella Grasso; Daniela Drandi; Mario Boccadoro; Antonio Palumbo
Cells carrying nonlymphoma-associated bcl-2/IgH rearrangements (NLABR) are phenotypically related to follicular lymphoma and can establish as long-term persisting clonal populations
2006-01-01 LADETTO M; MANTOAN B; DE MARCO F; DRANDI D; AGUZZI C; ASTOLFI M; VALLET S; RICCA I; AQUILA MD; PAGLIANO G; MONITILLO L; POLLIO B; SANTO L; CRISTIANO C; ROCCI A; FRANCESE R; BODONI CL; BORCHIELLINI A; SCHINCO P; BOCCADORO M; TARELLA C
Immunoglobulin (Ig) Repertoire in Multiple Myeloma: High Frequency of Recurrent Aminoacid Substitutions in the FR2 and CDR2
2006-01-01 Marco Ladetto; Daniela Drandi; Loredana Santo; Barbara Mantoan; Michela Boi; Maria Dell’Aquila; Luigia Monitillo; Chiara Lobetti Bodoni; Antonio Palumbo; Monica Astolfi; Mario Boccadoro
Impact of Early Consolidation with Bortezomib, Thalidomide and Dexamethasone on Molecularly-Detectable Disease in MM Patients in CR or VGPR Following Autologous Transplantation: Uncommon Achievement of Molecular Remission Despite Evidence of Tumor Load Reduction by Real Time PCR
2006-01-01 Marco Ladetto; Monica Astolfi; Loredana Santo; Ilaria Avonto; Federica Cavallo; Gloria Pagliano; Patrizia Pregno; Mariella Grasso; Anna Marina Liberati; Tommaso Caravita; Francesco Pisani; Tommasina Guglielmelli; Elisa Genuardi; Rossana Crivelli; Carmen Cristiano; Daniela Drandi; Mario Boccadoro; Antonio Palumbo
Rituximab induces effective clearance of minimal residual disease in molecular relapses of mantle cell lymphoma
2006-01-01 LADETTO M; MAGNI M; PAGLIANO G; DE MARCO F; DRANDI D; RICCA I; ASTOLFI M; MATTEUCCI P; GUIDETTI A; MANTOAN B; LOBETTI BODONI C; ZANNI M; BOCCADORO M; GIANNI AM ;TARELLA C
Real-time polymerase chain reaction of immunoglobulin rearrangements for quantitative evaluation of minimal residual disease in myeloma
2005-01-01 Mara Compagno; Barbara Mantoan; Monica Astolfi; Mario Boccadoro; Marco Ladetto
Telomere Length Identifies Two Distinct Populations with Different Outcome among VH-Unmutated CLL Patients
2005-01-01 Irene Ricca; Alberto Rocci; Daniela Drandi; Mara Compagno; Roberto Francese; Paola Omedè; Loredana Santo; Michela Rosace; Federica De Marco; Monica Astolfi; Chiara Lobetti Bodoni; Maria Dell’Aquila; Sonia Vallet; Luciana Bergui; Andrea Gallamini; Carlo Marinone; Mario Boccadoro; Corrado Tarella; Marco Ladetto
Long-Term Monitoring of Cancer-Free Subjects Carrying Non-Lymphoma Associated bcl2/IgH Rearrangements (NLABR): Prolonged Persistence of Clonal Populations Potentially Related to Follicular Lymphoma (FL)
2004-01-01 Marco Ladetto; Barbara Mantoan; Federica De Marco; Berardino Pollio; Daniela Drandi; Irene Ricca; Sonia Vallet; Mara Compagno; Monica Astolfi; Maria Dell’Aquila; Roberto Francese; Gloria Pagliano; Luigia Monitillo; Giacomo Tamponi; Mario Boccadoro; Corrado Tarella
Cyclooxygenase-2 (COX-2) Is Frequently Expressed in Multiple Myeloma (MM) and Is Associated with Poor Outcome
2004-01-01 Marco Ladetto; Sonia Vallet; Andreas Trojan; Maria Dell’Aquila; Luigia Monitillo; Loredana Santo; Alessandra Bertola; Patrizia Falco; Federica Cavallo; Daniela Drandi; Irene Ricca; Gloria Pagliano; Monica Astolfi; Alberto Rocci; Beata Bode; Antonio Palumbo; Corrado Tarella; Paola Omedé; Mario Boccadoro
Telomere length correlates with histopathogenesis according to the germinal center in mature B-cell lymphoproliferative disorders
2004-01-01 LADETTO M; COMPAGNO M; RICCA I; PAGANO M; ROCCI A; ASTOLFI M; DRANDI D; DI CELLE PF; DELL'AQUILA M; MANTOAN B; VALLET S; PAGLIANO G; DE MARCO F; FRANCESE R; SANTO L; CUTTICA A; MARINONE C; BOCCADORO M; TARELLA C.
Sequential Brief Chemo-Immunotherapy FND + Rituximab in Elderly Patients with Advanced Stage Follicular Lymphoma (FL): High Clinical and Molecular Remission Rate Associated with a Prolonged Failure-Free Survival
2004-01-01 Umberto Vitolo; Carola Boccomini; Marco Ladetto; Enrico Pogliani; Delia Rota Scalabrini; Corrado Tarella; Claudia Castellino; Massimo Aglietta; Monica Astolfi; Andrea Carpaneto; Paolo Corradini; Antonella Darbesio; Alberto De Crescenzo; Alessandro Levis; Anna Marina Liberati; Sergio Morandi; Lorella Orsucci; Patrizia Pregno; Luigi Rigacci; Fausto Rossini; Anna Tonso; Eugenio Gallo
Telomerase Inhibitor BIBR1532 Induces Telomere Shortening and Growth Inhibition in Extra-Germinal Center (GC)-Derived Lymphoid Cell Lines
2004-01-01 Marco Ladetto; Irene Ricca; Mara Compagno; Dario Ferrero; Alberto Rocci; Maria Dell’Aquila; Paola Omedè; Roberto Francese; Federica De Marco; Sonia Vallet; Loredana Santo; Daniela Drandi; Monica Astolfi; Mario Boccadoro; Corrado Tarella
Long-Term Outcome of High-Dose Sequential Chemotherapy with Autografting (i-HDS) in Follicular Lymphoma at Diagnosis: An Update of the Prospective Multicenter Consecutive Trial of the "Gruppo Italiano Trapianto Di Midollo Osseo" (Gitmo)
2004-01-01 Marco Ladetto; Sonia Vallet; Paolo Corradini; Fabio Benedetti; Umberto Vitolo; Maurizio Martelli; Vincenzo Callea; Paolo Coser; Alessio Perrotti; Caterina Patti; Giuseppe Fioritoni; Sergio Morandi; Maurizio Musso; Renato Zambello; Monica Astolfi; Alessandro Pileri; Mario Boccadoro; Corrado Tarella
Qualitative and Quantitative Molecular Follow up of Minimal Residual Disease after Non Myeloablative Allografting for Multiple Myeloma.
2004-01-01 B. Bruno; M. Ladetto; M. Astolfi; L. Veneziano; L. Cimolin; E. Galletto; G. Pagliano; M. Rotta; N. Mordini; L. Giaccone; P. Omedè; S. Battaglio; R. Storb; and M. Boccadoro
Long-term follow-up of indolent lymphoma patients treated with high-dose sequential chemotherapy and autografting: evidence that durable molecular and clinical remission frequently can be attained only in follicular subtypes
2004-01-01 CORRADINI P; LADETTO M; ZALLIO F; ASTOLFI M; RIZZO E; SAMETTI S; CUTTICA A; ROSATO R; FARINA L; BOCCADORO M; BENEDETTI F; PILERI A; TARELLA C
PCR-detectable non-neoplastic Bcl-2/IgH rearrangements are common in normal subjects and cancer patients at diagnosis, but rare in subjects treated with chemotherapy.
2003-01-01 Ladetto M; Drandi D; Volpato F; Astolfi M; Voena C; Compagno M; Novarino A; Pollio B; Addeo A; Ricca I; Falco P; Cavallo F; Vallet S; Corradini P; Pileri A; Tamponi G; Palumbo A; Bertetto O; Boccadoro M; Tarella C
Molecular monitoring of minimal residual disease after non-myeloablative allografting for multiple myeloma
2003-01-01 Bruno B; Ladetto M; Mordini N; Astolfi M; Rotta M; Cimolin L; Compagno M; Veneziano L; Aitoro G; Gallamini A ; Storb R; Boccadoro M
Concurrent administration of high-dose chemotherapy and rituximab is a feasible and effective chemo/immunotherapy for patients with high-risk non-Hodgkin's lymphoma.
2001-01-01 LADETTO M; ZALLIO F; VALLET S; RICCA I; CUTTICA A; CARACCIOLO D; CORRADINI P; ASTOLFI M; SAMETTI S; VOLPATO F; BONDESAN P; VITOLO U; M. BOCCADORO; PILERI A; GIANNI AM; TARELLA C.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Immunophenotypic profile and cytogenetic aberrations detected by interphase FISH in B-CLL patients | 2011 | Ruggeri M; Caltagirone S; Gilestro M; Aschero S; Astolfi M; Oddolo D; Saraci E; Muccio VE; Bergui L; Coscia M; Omedè P; Boccadoro M | |
| 12p, 1p, 1q, 5q, 11q ABNORMALITIES AND IMMUNOPHENOTYPE IN MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE, MULTIPLE MYELOMA AND PLASMA CELL LEUKEMIA. | 2010 | Ruggeri M; Caltagirone S; Gilestro M; Aschero S; Astolfi M; Oddolo D; Saraci E; Bruno B; Palumbo A; Bringhen S; Cavallo F; Omedè P; Boccadoro M | |
| Consolidation with Bortezomib, Thalidomide and Dexamethasone Induces Molecular Remissions in Autografted Multiple Myeloma Patients | 2007 | Marco Ladetto; Gloria Pagliano; Ilaria Avonto; Loredana Santo; Simone Ferrero; Federica Cavallo; Monica Astolfi; Patrizia Pregno; Claudia Crippa; Anna Marina Liberati; Vincenzo Callea; Luca De Rosa; Antonietta Falcone; Mariella Grasso; Daniela Drandi; Mario Boccadoro; Antonio Palumbo | |
| Cells carrying nonlymphoma-associated bcl-2/IgH rearrangements (NLABR) are phenotypically related to follicular lymphoma and can establish as long-term persisting clonal populations | 2006 | LADETTO M; MANTOAN B; DE MARCO F; DRANDI D; AGUZZI C; ASTOLFI M; VALLET S; RICCA I; AQUILA MD; PAGLIANO G; MONITILLO L; POLLIO B; SANTO L; CRISTIANO C; ROCCI A; FRANCESE R; BODONI CL; BORCHIELLINI A; SCHINCO P; BOCCADORO M; TARELLA C | |
| Immunoglobulin (Ig) Repertoire in Multiple Myeloma: High Frequency of Recurrent Aminoacid Substitutions in the FR2 and CDR2 | 2006 | Marco Ladetto; Daniela Drandi; Loredana Santo; Barbara Mantoan; Michela Boi; Maria Dell’Aquila; Luigia Monitillo; Chiara Lobetti Bodoni; Antonio Palumbo; Monica Astolfi; Mario Boccadoro | |
| Impact of Early Consolidation with Bortezomib, Thalidomide and Dexamethasone on Molecularly-Detectable Disease in MM Patients in CR or VGPR Following Autologous Transplantation: Uncommon Achievement of Molecular Remission Despite Evidence of Tumor Load Reduction by Real Time PCR | 2006 | Marco Ladetto; Monica Astolfi; Loredana Santo; Ilaria Avonto; Federica Cavallo; Gloria Pagliano; Patrizia Pregno; Mariella Grasso; Anna Marina Liberati; Tommaso Caravita; Francesco Pisani; Tommasina Guglielmelli; Elisa Genuardi; Rossana Crivelli; Carmen Cristiano; Daniela Drandi; Mario Boccadoro; Antonio Palumbo | |
| Rituximab induces effective clearance of minimal residual disease in molecular relapses of mantle cell lymphoma | 2006 | LADETTO M; MAGNI M; PAGLIANO G; DE MARCO F; DRANDI D; RICCA I; ASTOLFI M; MATTEUCCI P; GUIDETTI A; MANTOAN B; LOBETTI BODONI C; ZANNI M; BOCCADORO M; GIANNI AM ;TARELLA C | |
| Real-time polymerase chain reaction of immunoglobulin rearrangements for quantitative evaluation of minimal residual disease in myeloma | 2005 | Mara Compagno; Barbara Mantoan; Monica Astolfi; Mario Boccadoro; Marco Ladetto | |
| Telomere Length Identifies Two Distinct Populations with Different Outcome among VH-Unmutated CLL Patients | 2005 | Irene Ricca; Alberto Rocci; Daniela Drandi; Mara Compagno; Roberto Francese; Paola Omedè; Loredana Santo; Michela Rosace; Federica De Marco; Monica Astolfi; Chiara Lobetti Bodoni; Maria Dell’Aquila; Sonia Vallet; Luciana Bergui; Andrea Gallamini; Carlo Marinone; Mario Boccadoro; Corrado Tarella; Marco Ladetto | |
| Long-Term Monitoring of Cancer-Free Subjects Carrying Non-Lymphoma Associated bcl2/IgH Rearrangements (NLABR): Prolonged Persistence of Clonal Populations Potentially Related to Follicular Lymphoma (FL) | 2004 | Marco Ladetto; Barbara Mantoan; Federica De Marco; Berardino Pollio; Daniela Drandi; Irene Ricca; Sonia Vallet; Mara Compagno; Monica Astolfi; Maria Dell’Aquila; Roberto Francese; Gloria Pagliano; Luigia Monitillo; Giacomo Tamponi; Mario Boccadoro; Corrado Tarella | |
| Cyclooxygenase-2 (COX-2) Is Frequently Expressed in Multiple Myeloma (MM) and Is Associated with Poor Outcome | 2004 | Marco Ladetto; Sonia Vallet; Andreas Trojan; Maria Dell’Aquila; Luigia Monitillo; Loredana Santo; Alessandra Bertola; Patrizia Falco; Federica Cavallo; Daniela Drandi; Irene Ricca; Gloria Pagliano; Monica Astolfi; Alberto Rocci; Beata Bode; Antonio Palumbo; Corrado Tarella; Paola Omedé; Mario Boccadoro | |
| Telomere length correlates with histopathogenesis according to the germinal center in mature B-cell lymphoproliferative disorders | 2004 | LADETTO M; COMPAGNO M; RICCA I; PAGANO M; ROCCI A; ASTOLFI M; DRANDI D; DI CELLE PF; DELL'AQUILA M; MANTOAN B; VALLET S; PAGLIANO G; DE MARCO F; FRANCESE R; SANTO L; CUTTICA A; MARINONE C; BOCCADORO M; TARELLA C. | |
| Sequential Brief Chemo-Immunotherapy FND + Rituximab in Elderly Patients with Advanced Stage Follicular Lymphoma (FL): High Clinical and Molecular Remission Rate Associated with a Prolonged Failure-Free Survival | 2004 | Umberto Vitolo; Carola Boccomini; Marco Ladetto; Enrico Pogliani; Delia Rota Scalabrini; Corrado Tarella; Claudia Castellino; Massimo Aglietta; Monica Astolfi; Andrea Carpaneto; Paolo Corradini; Antonella Darbesio; Alberto De Crescenzo; Alessandro Levis; Anna Marina Liberati; Sergio Morandi; Lorella Orsucci; Patrizia Pregno; Luigi Rigacci; Fausto Rossini; Anna Tonso; Eugenio Gallo | |
| Telomerase Inhibitor BIBR1532 Induces Telomere Shortening and Growth Inhibition in Extra-Germinal Center (GC)-Derived Lymphoid Cell Lines | 2004 | Marco Ladetto; Irene Ricca; Mara Compagno; Dario Ferrero; Alberto Rocci; Maria Dell’Aquila; Paola Omedè; Roberto Francese; Federica De Marco; Sonia Vallet; Loredana Santo; Daniela Drandi; Monica Astolfi; Mario Boccadoro; Corrado Tarella | |
| Long-Term Outcome of High-Dose Sequential Chemotherapy with Autografting (i-HDS) in Follicular Lymphoma at Diagnosis: An Update of the Prospective Multicenter Consecutive Trial of the "Gruppo Italiano Trapianto Di Midollo Osseo" (Gitmo) | 2004 | Marco Ladetto; Sonia Vallet; Paolo Corradini; Fabio Benedetti; Umberto Vitolo; Maurizio Martelli; Vincenzo Callea; Paolo Coser; Alessio Perrotti; Caterina Patti; Giuseppe Fioritoni; Sergio Morandi; Maurizio Musso; Renato Zambello; Monica Astolfi; Alessandro Pileri; Mario Boccadoro; Corrado Tarella | |
| Qualitative and Quantitative Molecular Follow up of Minimal Residual Disease after Non Myeloablative Allografting for Multiple Myeloma. | 2004 | B. Bruno; M. Ladetto; M. Astolfi; L. Veneziano; L. Cimolin; E. Galletto; G. Pagliano; M. Rotta; N. Mordini; L. Giaccone; P. Omedè; S. Battaglio; R. Storb; and M. Boccadoro | |
| Long-term follow-up of indolent lymphoma patients treated with high-dose sequential chemotherapy and autografting: evidence that durable molecular and clinical remission frequently can be attained only in follicular subtypes | 2004 | CORRADINI P; LADETTO M; ZALLIO F; ASTOLFI M; RIZZO E; SAMETTI S; CUTTICA A; ROSATO R; FARINA L; BOCCADORO M; BENEDETTI F; PILERI A; TARELLA C | |
| PCR-detectable non-neoplastic Bcl-2/IgH rearrangements are common in normal subjects and cancer patients at diagnosis, but rare in subjects treated with chemotherapy. | 2003 | Ladetto M; Drandi D; Volpato F; Astolfi M; Voena C; Compagno M; Novarino A; Pollio B; Addeo A; Ricca I; Falco P; Cavallo F; Vallet S; Corradini P; Pileri A; Tamponi G; Palumbo A; Bertetto O; Boccadoro M; Tarella C | |
| Molecular monitoring of minimal residual disease after non-myeloablative allografting for multiple myeloma | 2003 | Bruno B; Ladetto M; Mordini N; Astolfi M; Rotta M; Cimolin L; Compagno M; Veneziano L; Aitoro G; Gallamini A ; Storb R; Boccadoro M | |
| Concurrent administration of high-dose chemotherapy and rituximab is a feasible and effective chemo/immunotherapy for patients with high-risk non-Hodgkin's lymphoma. | 2001 | LADETTO M; ZALLIO F; VALLET S; RICCA I; CUTTICA A; CARACCIOLO D; CORRADINI P; ASTOLFI M; SAMETTI S; VOLPATO F; BONDESAN P; VITOLO U; M. BOCCADORO; PILERI A; GIANNI AM; TARELLA C. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile